|[September 03, 2013]
Retrophin to Present at the Stifel Healthcare Conference 2013
NEW YORK --(Business Wire)--
Retrophin, Inc. (OTCQB: RTRX) today announced that Martin Shkreli,
Founder, President and Chief Executive Officer, will present an overview
of the Company at the Stifel Healthcare Conference 2013 on Wednesday,
September 11, 2013 at 4:25pm ET at the Four Seasons Hotel in Boston, MA.
A live webcast and 30-day archive of the Retrophin presentation can be
accessed at http://www.veracast.com/webcasts/stifel/healthcare2013/68114573143.cfm.
The webcast will also be available on the Company's website, www.retrophin.com,
in the Investors/Events & Presentations section.
Retrophin is a pharmaceutical company focused on the discovery and
development of drugs for the treatment of debilitating and often
life-threatening diseases for which there are currently no viable
patient options. The Company is currently focused on several
catastrophic diseases affecting children, including Focal Segmental
Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated
Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and others.
Retrophin's lead compound, RE-021, is scheduled to begin enrollment in a
potentially pivotal Phase 2 clinical trial for FSGS during 2013. For
additional information, please visit www.retrophin.com.
This press release contains "forward-looking statements" as that term is
defined in the Private Securities Litigation Reform Act of 1995,
regarding the research, development and commercialization of
pharmaceutical products. Such forward-looking statements are based on
current expectations and involve inherent risks and uncertainties,
including factors that could delay, divert or change any of them, and
could cause actual outcomes and results to differ materially from
current expectations. No forward-looking statement can be guaranteed.
Forward-looking statements in the press release should be evaluated
together with the many uncertainties that affect the Company's business.
The Company undertakes no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future events, or otherwise.
[ Back To Technology News's Homepage ]